MOLOGEN Lifescience AG Statistics

Total Valuation

FRA:U1DA has a market cap or net worth of EUR 3.86 million.

Market Cap	3.86M
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

FRA:U1DA has 1.38 million shares outstanding.

Current Share Class	1.38M
Shares Outstanding	1.38M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	85.64
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.49

Current Ratio	7.49
Quick Ratio	0.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-7.40%
Weighted Average Cost of Capital (WACC)	7.29%
Revenue Per Employee	45,121
Profits Per Employee	-85,288
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.33% in the last 52 weeks. The beta is 0.55, so FRA:U1DA's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+33.33%
50-Day Moving Average	2.87
200-Day Moving Average	2.87
Relative Strength Index (RSI)	50.30
Average Volume (20 Days)	15

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:U1DA had revenue of EUR 45,121 and -85,288 in losses.

Revenue	45,121
Gross Profit	45,527
Operating Income	-76,614
Pretax Income	-85,288
Net Income	-85,288
EBITDA	n/a
EBIT	-76,614
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 14,816 in cash and no debt, with a net cash position of 14,816 or 0.01 per share.

Cash & Cash Equivalents	14,816
Total Debt	n/a
Net Cash	14,816
Net Cash Per Share	0.01
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	1.03M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.90%, with operating and profit margins of -169.80% and -189.02%.

Gross Margin	100.90%
Operating Margin	-169.80%
Pretax Margin	-189.02%
Profit Margin	-189.02%
EBITDA Margin	n/a
EBIT Margin	-169.80%
FCF Margin	n/a

Dividends & Yields

FRA:U1DA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.21%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 2, 2022. It was a reverse split with a ratio of 0.01.

Last Split Date	Feb 2, 2022
Split Type	Reverse
Split Ratio	0.01

Scores

FRA:U1DA has an Altman Z-Score of 1.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.03
Piotroski F-Score	n/a